Research
-
FDA approves Gazyva® (obinutuzumab), expanding therapeutic options for treatment of adults with lupus nephritis
.
FDA approval of Gazyva expands therapeutic options for lupus care The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults…
-
Clinical Trials in Lupus Research
.
Scientists, researchers, and volunteers all have a part to play in advancing clinical trial research. It’s thanks to the collaborative efforts of these groups that we have ways to…
-
NEWS: A Cancer therapy might offer hope for patients with lupus
.
From the New York Times by Nina Agrawal, Times health reporter Jennifer Le’s doctor ticked through a long checklist of head-to-toe symptoms as she examined Ms. Le in a…